These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6430640)

  • 1. Plasma levels and progestational activity of levonorgestrel after repeated intravenous and subcutaneous administration in the beagle bitch.
    Düsterberg B; Beier S
    Contraception; 1984 Apr; 29(4):345-57. PubMed ID: 6430640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dose on the pharmacokinetics of levonorgestrel in the rat during the rapid elimination phase following subcutaneous administration.
    Naqvi RH; Mitra SB; Lindberg MC
    Contraception; 1984 Dec; 30(6):599-605. PubMed ID: 6442230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of interaction between levonorgestrel and ethanol.
    Gomaa AA; Osman FH; Salem HT; Abdel Wareth AA
    Contraception; 1984 Jun; 29(6):535-42. PubMed ID: 6432432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of levonorgestrel, gestodene, norethisterone and cyproterone acetate on single-dose subcutaneous administration in oily solution in the rat, beagle and rhesus monkey.
    Düsterberg B
    Steroids; 1984 Jan; 43(1):43-56. PubMed ID: 6240802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic effects of ethinyl estradiol in women using vaginal devices releasing small doses of levonorgestrel at a constant rate.
    Toddyvalla V; Johannisson E; Landgren BM; Cekan SZ; Diczfalusy E
    Contraception; 1983 Jul; 28(1):21-39. PubMed ID: 6414759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
    Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigations of pharmacokinetics of levonorgestrel to specific consideration of a possible first-pass effect in women.
    Hümpel M; Wendt H; Pommerenke G; Weiss C; Speck U
    Contraception; 1978 Mar; 17(3):207-20. PubMed ID: 648145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Terminal half-lives in plasma and bioavailability of norethisterone, levonorgestrel, cyproterone acetate and gestodene in rats, beagles and rhesus monkeys.
    Düsterberg B; Hümpel M; Speck U
    Contraception; 1981 Dec; 24(6):673-83. PubMed ID: 6459908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of gestagens: some problems.
    Fotherby K
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):323-8. PubMed ID: 2115297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal consequences of missing the pill during the first two days of three consecutive artificial cycles.
    Landgren BM; Diczfalusy E
    Contraception; 1984 May; 29(5):437-46. PubMed ID: 6430642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood levels of levonorgestrel in women following vaginal placement of contraceptive pills.
    Alvarez F; Faundes A; Johansson E; Coutinho E
    Fertil Steril; 1983 Jul; 40(1):120-3. PubMed ID: 6407876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in vaginal cytograms of female beagle dogs during toxicologic long-term examinations of gestagens].
    Strecke J; Oettel M; Hillesheim HG; Hoffmann H
    Z Versuchstierkd; 1982; 24(3):117-25. PubMed ID: 6814094
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of different contraceptive treatments on the serum concentration of dehydroepiandrosterone sulfate.
    Klove KL; Roy S; Lobo RA
    Contraception; 1984 Apr; 29(4):319-24. PubMed ID: 6235099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of STS 557 on the mitotic activity in the endometrium of ovariectomized mice and comparison with the effects of progesterone and levonorgestrel.
    Koch M
    Exp Clin Endocrinol; 1984 May; 83(3):310-4. PubMed ID: 6432566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levonorgestrel plasma levels during continuous administration with different models of subdermal implants.
    Alvarez F; Brache V; Faundes A; Johansson ED; Odlind V; Nash H
    Contraception; 1983 Feb; 27(2):123-30. PubMed ID: 6406138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical pharmacological study of a new type of vaginal delivery system for levonorgestrel.
    Landgren BM; Johannisson E; Xing S; Aedo AR; Diczfalusy E
    Contraception; 1985 Dec; 32(6):581-601. PubMed ID: 3937664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of levonorgestrel in Indian women belonging to low socio-economic group.
    Nair KM; Sivakumar B; Prema K; Rao BS
    Contraception; 1979 Sep; 20(3):303-17. PubMed ID: 509957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levonorgestrel and progesterone levels in women treated with silastic covered rods containing levonorgestrel.
    Croxatto HB; Díaz S; Brandeis A; Pavez M; Johansson ED
    Contraception; 1985 Jun; 31(6):643-54. PubMed ID: 3930143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian function is effectively inhibited by a low-dose triphasic oral contraceptive containing ethinylestradiol and levonorgestrel.
    Gaspard UJ; Dubois M; Gillain D; Franchimont P; Duvivier J
    Contraception; 1984 Apr; 29(4):305-18. PubMed ID: 6430638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian function in amenorrheic and menstruating users of a levonorgestrel-releasing intrauterine device.
    Nilsson CG; Lähteenmäki PL; Luukkainen T
    Fertil Steril; 1984 Jan; 41(1):52-5. PubMed ID: 6420203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.